198 related articles for article (PubMed ID: 33475150)
1. Compartmentation of β
Rudokas MW; Post JP; Sataray-Rodriguez A; Sherpa RT; Moshal KS; Agarwal SR; Harvey RD
Br J Pharmacol; 2021 Apr; 178(7):1574-1587. PubMed ID: 33475150
[TBL] [Abstract][Full Text] [Related]
2. Caveolae compartmentalise β2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte.
Macdougall DA; Agarwal SR; Stopford EA; Chu H; Collins JA; Longster AL; Colyer J; Harvey RD; Calaghan S
J Mol Cell Cardiol; 2012 Feb; 52(2):388-400. PubMed ID: 21740911
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
Nikolaev VO; Bünemann M; Schmitteckert E; Lohse MJ; Engelhardt S
Circ Res; 2006 Nov; 99(10):1084-91. PubMed ID: 17038640
[TBL] [Abstract][Full Text] [Related]
4. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
Bastug-Özel Z; Wright PT; Kraft AE; Pavlovic D; Howie J; Froese A; Fuller W; Gorelik J; Shattock MJ; Nikolaev VO
Cardiovasc Res; 2019 Mar; 115(3):546-555. PubMed ID: 30165515
[TBL] [Abstract][Full Text] [Related]
5. Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.
Jurevicius J; Skeberdis VA; Fischmeister R
J Physiol; 2003 Aug; 551(Pt 1):239-52. PubMed ID: 12815180
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases.
Leroy J; Abi-Gerges A; Nikolaev VO; Richter W; Lechêne P; Mazet JL; Conti M; Fischmeister R; Vandecasteele G
Circ Res; 2008 May; 102(9):1091-100. PubMed ID: 18369156
[TBL] [Abstract][Full Text] [Related]
7. A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes.
Rochais F; Abi-Gerges A; Horner K; Lefebvre F; Cooper DM; Conti M; Fischmeister R; Vandecasteele G
Circ Res; 2006 Apr; 98(8):1081-8. PubMed ID: 16556871
[TBL] [Abstract][Full Text] [Related]
8. PDE4 and mAKAPβ are nodal organizers of β2-ARs nuclear PKA signalling in cardiac myocytes.
Bedioune I; Lefebvre F; Lechêne P; Varin A; Domergue V; Kapiloff MS; Fischmeister R; Vandecasteele G
Cardiovasc Res; 2018 Sep; 114(11):1499-1511. PubMed ID: 29733383
[TBL] [Abstract][Full Text] [Related]
9. Influence of cell confluence on the cAMP signalling pathway in vascular smooth muscle cells.
Belacel-Ouari M; Zhang L; Hubert F; Assaly R; Gerbier R; Jockers R; Dauphin F; Lechêne P; Fischmeister R; Manoury B; Leblais V
Cell Signal; 2017 Jul; 35():118-128. PubMed ID: 28389413
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
11. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
[TBL] [Abstract][Full Text] [Related]
12. Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.
Christ T; Galindo-Tovar A; Thoms M; Ravens U; Kaumann AJ
Br J Pharmacol; 2009 Jan; 156(1):62-83. PubMed ID: 19133992
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
[TBL] [Abstract][Full Text] [Related]
14. PDE2 activity differs in right and left rat ventricular myocardium and differentially regulates β2 adrenoceptor-mediated effects.
Soler F; Fernández-Belda F; Pérez-Schindler J; Handschin C; Fuente T; Hernandez-Cascales J
Exp Biol Med (Maywood); 2015 Sep; 240(9):1205-13. PubMed ID: 25432985
[TBL] [Abstract][Full Text] [Related]
15. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
[TBL] [Abstract][Full Text] [Related]
17. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
[TBL] [Abstract][Full Text] [Related]
18. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
[TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of cAMP in brown adipocytes reveals differential compartmentation of β
Kannabiran SA; Gosejacob D; Niemann B; Nikolaev VO; Pfeifer A
Mol Metab; 2020 Jul; 37():100986. PubMed ID: 32247064
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
